Pressroom

 

Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in JAMA Oncology.
Thursday, July 18, 2019
 
Today is the fourth anniversary of same-sex marriage being legalized in the United States. Today also marks the start of WorldPride, which celebrates the progress made toward LGBTQ+ equality while underscoring changes still needed.
Thursday, June 27, 2019
 
Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.
Tuesday, June 11, 2019
 

See all trending topics
 

Press Releases

 

Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared new data from a survey of members of the Society of Gynecologic Oncology (SGO) showing that sexual harassment and observed gender discrimination continue to be significant issues in the medical community. The results of the study found that more than 60 percent of gynecologic oncologists had experienced sexual harassment, while only 10 percent of survey respondents reported the incident. The findings were presented as part of the press program for this year’s annual meeting of the American Society of Clinical Oncology (ASCO).
Monday, June 3, 2019
 
Michael P. Harrington has been named Executive Vice President and Chief Financial Officer (CFO) at Memorial Sloan Kettering Cancer Center (MSK). Mr. Harrington currently serves as the Associate Chief Financial Officer at the Cleveland Clinic. His appointment concludes a national search to identify a successor for MSK’s current CFO, Michael Gutnick, who will retire after 42 years of exemplary service to MSK.
Wednesday, April 10, 2019
 
Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.
Thursday, April 4, 2019
 

See all press releases
 

On Our Blog

 

FEATURE
Meet one of MSK’s gynecologic oncology fellows. Learn what it’s like to be part of an intensive training program alongside leaders in cancer care and research.
Thursday, July 18, 2019
 
IN THE LAB
Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.
Wednesday, July 17, 2019
 
IN THE CLINIC
Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.
Tuesday, July 16, 2019
 

See all blog posts
 

Media Coverage

 

The NY Daily News featured a story on an MSK Kids patient and featured MSK’s Ira Dunkel
Wednesday, July 3, 2019
 
As June is both Pride Month and Cancer Survivor Month, MSK’s Chasity Burrows Walters addresses the need for more data to help understand and address disparities among LGBTQ cancer patients and survivors in an in-studio live interview on NY1.
Saturday, June 29, 2019
 
Regardless of gender identity or sexual orientation, cancer doesn’t discriminate, but access to treatment and quality care might. MSK’s Nelson Sanchez and MSK patient are profiled. 
Friday, June 28, 2019
 

See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Media Relations Manager, Surgery
 
Courtney Nowak
Media Relations Manager, Regional Care Network
 
Caitlin Hool
Senior Manager, Media Relations and Partnerships
 
Nicole H. McNamara
Senior Media Strategist
 
Rebecca Williams
Media Strategist
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Contact our Media Staff